Chapter 19: Proteins in Plasma and Urine

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome to a special 101 tutoring session designed specifically for you college students out there.

Yeah, if you are tackling clinical biochemistry right now, you are in the exact right place.

Whether you're, you know, prepping for a looming exam, trying to connect the dots for clinical rotations or just trying to finally make sense of your textbook.

We are diving deep into chapter 19 today.

Right, from clinical biochemistry and metabolic medicine.

Specifically focusing on the biochemistry of proteins in plasma and urine.

And we really want to unpack this in the exact order it appears in the text.

Exactly.

The best way to master this material is to build it up logically, step by step.

So we'll start by looking at normal physiological principles, you know, how proteins are synthesized and what they actually do.

Because once you understand the normal pathways, we can look at what happens when those pathways break down.

The pathophysiology.

Right.

And from there, you can perfectly predict the laboratory abnormalities you'll see on an exam or in the clinic.

Which then dictates clinical management.

It's a complete logical loop.

So our mission today is to hit plasma protein metabolism, the acute phase response, immune system cascades, B -cell disorders like multiple myeloma, and then finish up with urinary proteins and nephrotic syndrome.

Sounds like a plan.

Let's start with the absolute basics.

Where do these plasma proteins come from?

Well, in a healthy body, the hepatocytes in the liver are your main factories.

They synthesize the vast majority of our plasma proteins.

The major exception being our immunoglobulins, right?

Yes.

Those are manufactured by our immune system's B -lymphocytes.

Okay, so the liver and the B -cells make them.

Who breaks them down?

Once they've done their job, endothelial cells and phagocytes break them down.

But while they're floating around in the blood, they're performing three really vital functions.

The most physically obvious function is controlling extracellular fluid distribution.

And albumin is the star player here.

It is.

Albumin generates colloid osmotic pressure.

You can kind of think of albumin as a biological sponge inside your blood vessels.

A sponge that pulls water in.

Exactly.

Its physical presence creates a pulling force that keeps water inside the vasculature, instead of just letting it leak out into your surrounding tissues.

So that's osmotic pressure.

What's the second function?

Transport.

Many critical substances in the body, like lipids, calcium, and certain drugs, are poorly soluble in water.

Right, they can't just float freely.

No, they need protein chaperones to travel safely through the watery environment of the blood.

And the third major function is defense.

Which relies on the inflammatory response and infection control, orchestrated by our circulating antibodies and complement proteins.

But before we get deep into the immune system, we have to talk about how a laboratory actually evaluates these proteins.

Yeah, there is a huge trap that a lot of students fall into right here.

You have to firmly distinguish between measuring a protein's concentration and measuring its biological activity.

That distinction changes entirely how we diagnose diseases.

Because you could have a normal amount of a protein, but it might be useless.

Right.

You can draw a patient's blood and find a completely normal concentration of a specific protein.

Say, 5 grams per liter.

But if that protein is a dysfunctional mutated version, its actual working activity is zero.

Which is exceptionally critical when we're evaluating enzymes or clotting cascades.

Absolutely.

A patient might have normal circulating levels of C1 inhibitor protein, but if the molecule is structurally flawed and doesn't work, that patient is still going to suffer from severe inflammatory disease.

So to actually visualize what is happening with these proteins, clinical labs use serum electrophoresis.

Think of the electrophoresis strip as a fingerprint of the immune system.

It doesn't just tell you what proteins are there, it tells you exactly what kind of war the body is fighting.

You apply a little serum to a specialized gel strip, run an electrical current across it, and the proteins migrate and separate based on their individual electrical charges.

And the textbook makes a really big deal out of this.

It is crucial that we use serum, not plasma, for this test.

The reason for that comes down to clotting factors.

If you run plasma through an electrophoresis gel, the fibrinogen, which is a massive clotting protein,

migrates and forms a very distinct dark band right in the middle of your result.

It completely obscures the other proteins.

It makes interpretation nearly impossible.

So by letting the blood sample clot in the tube first, and using the leftover serum, the fibrinogen is already consumed.

It's removed from the equation entirely.

Exactly.

So let's visualize a normal electrophoresis strip.

Picture a landscape.

On the far left, you have a massive dark mountain peak.

That's your albumin band, the most abundant protein.

And trailing behind it to the right are four smaller hills.

First is the alpha -1 band.

Which is almost entirely a protective protein called alpha -1 antitrypsin.

Next is the alpha -2 band.

Containing heavy weights like alpha -2 macroglobulin and haptoglobin.

Following that is the beta band.

Depending on the resolution of the gel, this sometimes splits.

You get beta -1, which carries transferin and LDL cholesterol, and beta -2, which houses the C3 complement protein.

And finally, on the far right, you have the gamma band.

And unlike the sharp peaks of the others, the normal gamma band is a broad, smooth smear.

Because it represents all of our different immunoglobulins, our circulating antibodies.

Right.

It's a mix of a ton of different variations, so it smears out.

But the shape of that landscape changes dramatically in specific disease states.

Yes.

If a patient is fighting off a localized acute infection, you see what we call an acute phase pattern.

The albumin mountain shrinks a bit.

But the alpha -1 and alpha -2 hills spike sharply upwards.

Alternatively, if a patient has chronic systemic inflammation,

the body is constantly pumping out tons of different antibodies.

So visually, that broad gamma smear on the right rises significantly.

We also see highly specific diagnostic patterns, like with liver cirrhosis.

Oh, the classic beta -gamma bridge.

Walk us through that.

In cirrhosis, the failing liver stops making albumin, so that first peak drocks.

At the same time, the body's IgA antibodies increase so dramatically that they physically fill in the gap between the beta and gamma bands, fusing them together into a solid bridge.

Exactly.

Now, compare that to nephrotic syndrome, where the kidneys are heavily damaged and act like a broken sieve.

They're leaking proteins into the air.

But they mostly leak small proteins.

So the small albumin molecules are lost, dropping the albumin peak.

But the massive alpha -2 macroglobulin molecules are way too big to leak out.

So the body ramps up production of everything to compensate.

Right, and you end up with an isolated, massive spike in the alpha -2 band alongside a very low albumin.

Fascinating.

And lastly, if you look at a strip and that alpha -1 hill is completely missing, that points straight to alpha -1 antitrypsin deficiency.

Spot on.

Let's look a bit closer at albumin itself.

At 65 kilodaltons, it is the heavyweight champion of the plasma, and it has a relatively long half -life of 20 days.

So when a patient presents with hypoalbuminemia low albumin, we can logically deduce the cause just by looking at the basic mechanics of the body.

The first potential cause is simple dilution.

Like if a patient in the hospital is pumped full of 5e saline.

Exactly.

The total amount of albumin hasn't actually changed, but its concentration in the blood drops because it's watered down.

The second mechanism is redistribution.

When you lie down for long periods, or if you have a systemic illness that makes your capillaries leaky, albumin shifts out of the bloodstream.

It redistributes into the interstitial space between your cells.

The third cause is decreased synthesis.

Your liver replaces about 4 % of your total albumin every single day.

But if the liver is destroyed by cirrhosis, or if a patient is severely malnourished and lacks the dietary nitrogen needed to build proteins, the factory simply shuts down.

The fourth mechanism is increased loss.

Which is what we see in nephrotic syndrome, where it pours out through the kidneys.

Or in patients with severe thermal burns, where the protein literally weeps out through the damaged skin.

And finally, there is increased catabolism.

In states of severe trauma, illness, or hyperthyroidism, the body's metabolic rate skyrockets, breaking down proteins way faster than the liver can possibly replace them.

The clinical consequences of low albumin are severe.

We mentioned osmotic pressure earlier.

Right.

If albumin drops too low, that biological sponge is gone.

Water leaks out of the blood vessels and pools in the tissues.

Causing clinical edema.

But there is also a major pharmacological consequence drug toxicity.

I find this mechanism so fascinating.

The idea that someone's normal medication dose suddenly becomes lethal just because their albumin dropped.

It's a vital concept for anyone prescribing medication.

Many common drugs, like the blood thinner warfarin, or salicylates, travel through the bloodstream physically bound to albumin molecules.

And only the free unbound portion of the drug is pharmacologically active.

Precisely.

If a patient develops severe hypoalbuminemia, there are far fewer albumin binding sites available.

So suddenly, a totally standard dose of warfarin becomes a massive dose of active, free warfarin.

Putting the patient at extreme risk for internal bleeding.

And this exact same toxicity happens if you prescribe two different drugs that compete for the exact same binding sites on the albumin molecule.

Because one drug bumps the other off into the free, active state.

That concept of supply and demand transitions us perfectly into the acute phase response.

When tissue is damaged by infection or trauma, local immune cells like macrophages release chemical alarm signals.

Specifically cytokines, like interleukin 1, interleukin 6, and tumor necrosis factor alpha.

These cytokines travel through the blood to the liver and tell it to completely overhaul its manufacturing priorities.

The liver effectively declares a state of emergency.

It begins mass producing positive acute phase reactants.

These are proteins specifically designed to handle tissue damage and fight infection.

Like C -reactive protein, or CRP, and fibrinogen.

But protein synthesis requires massive amounts of energy and amino acids.

So to fuel this emergency production, the liver actively halts the synthesis of negative

Primarily albumin and transferrin.

It is a literal biological form of wartime rationing.

Now CRP is an incredibly useful tool in clinical practice.

It spikes rapidly and predictably.

First off, it rises significantly in bacterial infections, but remains relatively low in viral infections.

Which really helps clinicians decide whether to prescribe antibiotics.

Second, in patients with inflammatory bowel disease, checking the CRP helps differentiate the pathology.

A CRP level consistently over 50 mg per liter points heavily toward Crohn's disease rather than ulcerative colitis.

Third, rheumatologists use it to track the severity of flare -ups in connective tissue diseases like rheumatoid arthritis.

And fourth, we use high sensitivity CRP assays to evaluate cardiovascular risk.

Because chronic subclinical inflammation damages the endothelial lining of blood vessels over time.

So a baseline CRP level over 3 mg per liter indicates a high risk for future cardiovascular disease.

And while CRP is the standard, procalcitonin is an emerging marker that shows even greater specificity for identifying severe bacterial sepsis.

So we've seen how the liver alters its protein factory during an attack.

But what exactly happens when those defensive proteins hit the front lines?

That brings us to the complement system.

Which is a group of proteins synthesized by macrophages and hepatocytes that circulate in the blood in a completely inactive form.

Acting like a dormant minefield until they are triggered.

The cascades can seem intimidating, but they really just follow three distinct pathways.

Right.

The classic pathway requires a pre -existing immune response.

It's triggered only when antibodies physically bind to an antigen, forming a complex that activates complement proteins C1, C4, and C2.

The alternative pathway, however, is your immune system's tripwire.

It doesn't need preformed antibodies.

It is triggered directly by simply bumping into bacterial cell walls or aggregated IGA.

Creating a rapid, self -perpetuating loop that churns out the active protein C3B.

The third is the mannose -binding lectin pathway, which recognizes specific sugars on pathogen surfaces.

But the brilliant part of the complement system is the convergence.

Regardless of which pathway acts as the trigger, they all funnel into a single,

spectacular They activate proteins C5 through C9.

Which physically assemble into the membrane attack complex.

Which literally punches microscopic holes into the membranes of invading bacteria, causing them to burst.

Clinically, understanding this cascade explains our lab testing for autoimmune diseases, like systemic lupus erythematosus, or SLE.

In SLE, the patient's body is constantly generating rogue immune complexes.

And these complexes constantly trigger the classic pathway.

Which burns through the body's supply of C3 and C4 proteins much faster than the liver can replace them.

Consequently, measuring low blood levels of C3 and C4 is a hallmark diagnostic indicator of active lupus.

To finish up the cellular response, we rely on phagocytes.

Neutrophils act as the rapid response, heavy infantry team for acute bacterial infections.

Macrophages are the cleanup crew, handling chronic inflammation and lingering debris.

And T -cells act as the generals, orchestrating the entire battlefield response via chemical messengers called lymphokines.

While also possessing the ability to directly assassinate virus -infected cells.

The T -cells coordinate directly with the B -cells, which produce our immunoglobulins, or antibodies.

Structurally, these are Y -shaped molecules constructed from paired, heavy, and light protein chains.

The very tips of the Y are the fab regions, the variable binding sites.

These are infinitely customizable and bind to specific foreign antigens.

And the base of the Y is the FC region.

This is the constant effector region.

Once the ticks grab an antigen, the base signals the rest of the immune system to attack.

Remembering the five classes of immunoglobulins is kind of like remembering different branches of the military.

IgG is your standing army.

It's the most abundant, protects your extravascular tissue, and provides long -term immunity.

And it's the only antibody small enough to cross the placenta to protect a developing fetus.

IgM is your heavy artillery.

It's a massive pentamer, meaning five separate Y -shapes linked together into a massive structure.

Because of its sheer size, it cannot easily leave the bloodstream.

It is the absolute first responder to a new infection.

A critical clinical pearl here.

A fetus is capable of synthesizing its own IgM.

Therefore, if a newborn infant has high IgM levels in their blood, it proves they were exposed to an intruderine infection while still in the womb.

IgA is the new coastal protector.

It's found in saliva, tears, and the gut.

To survive those harsh, acidic environments, it uses a specialized J -chain and a secretory piece for structural integrity.

Finally, IgE is the specialized trigger for allergies and parasites.

It binds tightly to mast cells.

When it encounters an allergen, it triggers those mast cells to violently release histamine, causing type 1 hypersensitivity reactions like hay fever or full -blown anaphylaxis.

When these systems fail, we see specific immunodeficiencies.

Humoral deficiencies involving the antibodies can be transient.

For example, premature babies often experience a dangerous dip in immunity when the maternal IgG they received in the womb breaks down, before their own B -cells mature enough to produce replacement antibodies.

Primary humoral deficiencies are genetic, like Bruton's X -linked agamaglobulinemia, where B -cells are virtually absent from birth.

Secondary deficiencies occur later in life, often caused by losing antibodies in the urine due to nephrotic syndrome or having normal B -cells suppressed by a bone marrow cancer.

Cellular deficiencies primarily involve T -cells.

This includes genetic conditions like severe combined immunodeficiency or FCID.

It also includes HIV.

HIV specifically seeks out and destroys CD4 -positive T -cells.

When a patient's CD4 count drops below 200, the cellular generals are gone.

The immune system collapses and opportunistic infections take over.

We also have to consider deficiencies in specific individual proteins.

If a patient is born lacking the C1 esterase inhibitor protein, the complement cascade triggers inappropriately, leading to hereditary angineurotic edema.

Which causes unpredictable severe swelling of tissues, which can be rapidly fatal if it occurs in the larynx and blocks the airway.

And we absolutely have to detail alpha -1 antitrypsin deficiency.

The textbook emphasizes the PZ's genotype.

P and I simply stand for protease inhibitor.

The Z refers to a specific mutant allele.

If a patient inherits two copies, the ZZ genotype, the results are devastating for two entirely different organs.

Normally, this protein inhibits destructive enzymes like neutrophil elastase.

Without it, those enzymes run wild and chew through the structural elastin in the lungs, causing severe early onset emphysema.

At the exact same time, the liver is taking damage, but through a totally different mechanism.

The liver makes the mutant Z protein, but because it is misfolded, it cannot be secreted into the blood.

It physically gets trapped and aggregates inside the hepatocytes.

And this intracellular buildup destroys the liver cells, eventually leading to cirrhosis.

Let's pivot to what happens when B cells themselves become the problem.

Normally, an infection triggers thousands of different B cells to activate, producing a wide variety of antibodies.

This is a polyclonal response.

On an electrophoresis strip, this looks like a broad diffuse band.

But if a single solitary B cell mutates and begins dividing out of control, you get a massive clone army, all producing the exact same identical antibody.

This is a monoclonal response, and it creates a sharp, dense, unnatural spike on the electrophoresis strip, known as a paraprotein.

The most common and dangerous cause of a malignant paraprotein spike is multiple myeloma.

This is a cancer where malignant plasma cells proliferate uncontrollably inside the bone marrow.

The physical consequences are agonizing.

The expanding tumor cells bore into the surrounding bone, causing severe bone pain.

Leaving punched out, elytic lesions visible on x -rays.

The bone destruction releases massive amounts of calcium into the blood, leading to severe hypercalcemia.

And here is a fascinating lab finding for your exams.

Despite all that active bone destruction, the patient's alkaline phosphatase level usually remains completely normal.

Right.

Why?

Because the tumor originates in the marrow, not in the bone -forming cells.

There's no osteoblast activity attempting to repair the bone, so there's no spike in alkaline phosphatase.

Biochemically, the sheer volume of paraprotein being pumped into the blood makes it thick and syrupy, a condition called hyperviscosity.

Furthermore, this malignant clone army actively suppresses the remaining normal B cells.

Leading to immune paresis and leaving the patient highly vulnerable to normal infections.

Finally, the mutated tumor cells often produce incomplete antibody fragments.

Specifically, free light chains, known as Benz -Jones proteins.

These fragments are small enough to pass through the kidney's siltration system.

They accumulate in the delicate renal tubules, form dense casts, and physically destroy the kidneys, causing the classic myeloma kidney.

Let's walk through case one from the text to see exactly how a clinician pieces this together.

A 72 -year -old man presents with worsening back pain and generalized weakness.

His lab results reveal a urea of 13 .7 and a creatinine of 160, pointing clearly to renal failure.

His calcium is dangerously high at 3 .2A.

His total protein is sky high at 98 grams per liter, but his albumin is actually low at 34.

The clinical math there is incredibly revealing.

You take the total protein of 98 and you subtract the albumin of 34.

That leaves a massive 64 grams per liter of globulins.

That massive globulin gap demands further investigation.

When the lab ran a serum and urine electrophoresis, they discovered a sharp IgG capiparaprotein spike,

profound immune paresis of his normal antibodies, and heavily positive Benz -Jeans proteinuria.

Combined with the renal failure, high calcium, and back pain from lytic lesions, this is a definitive textbook diagnosis of multiple myeloma.

There are a few other B -cell disorders to be aware of.

Waldenstrom's macroglobulinemia is caused by a proliferation of lymphocytoid cells rather than pure plasma cells.

And the paraprotein is always IgM.

Because IgM is that massive five -part pentamer, profound hyperviscosity, thick blood, causing visual and neurological issues, is the major clinical symptom here.

We also see cryoglobulinemia, where the abnormal paraproteins literally precipitate and turn into a gel when exposed to cold temperatures.

A massive clinical pearl for practice.

If you suspect a patient has cryoglobulins, their blood sample must be collected in a warm tube and transported to the lab at exactly 37 degrees Celsius.

If that tube cools down during transport,

the proteins precipitate out of the serum and stick to the glass, and the lab will give you a false negative result.

We also frequently encounter MGUS monoclonal gramopathy of undetermined significance.

This is a small, benign paraprotein spike found mostly in elderly patients who have absolutely no symptoms.

It requires no immediate treatment, just a careful wait -and -see monitoring approach.

The last concept in this section is amyloidosis.

Sometimes, overproduced proteins like the free ale light chains from multiple myeloma, or a transport protein called transtheratin, a TTR, physically misfold.

They restructure themselves into highly stable, insoluble beta -pleated sheets.

These sheets deposit inside tissues like the heart, nerves, and kidneys, slowly destroying their function.

If you take a tissue biopsy, stain it with a specific dye called Congo Red, and view it under polarized light, the amyloid deposits glow with a striking classic apple green birefringence.

Which leads us perfectly into our final major topic, proteins in urine and the nephrotic syndrome.

In a healthy individual, the kidney's glomerular filtration barrier is incredibly strict.

It repels proteins that are large or negatively charged.

Consequently, a healthy person excretes less than a miniscule .08 grams of protein per day.

When a patient has significant provenuria, your job is to figure out the source.

Glomerular proteinuria means the main filtration barrier is leaking.

Sometimes this is entirely benign.

Orthostatic or postural proteinuria occurs frequently in tall, thin adolescents.

The physical pressure of standing all day forces mild protein leakage.

But if you test their overnight urine collection while they are lying down flat, the protein completely disappears.

However, glomerular leakage is often the first insidious sign of chronic disease.

We test for microalbuminuria, which is the loss of tiny amounts of albumin that standard clinic tip sticks are not sensitive enough to catch.

We quantify this early damage using the albumin to creatinine ratio, or ACR.

Case 2 illustrates the importance of the ACR perfectly.

A 65 -year -old man with poorly controlled type 2 diabetes comes in.

His HbA1c is severely elevated at 10%.

His urine ACR, which was previously normal, has jumped to 9 .9.

That rising ACR is a screaming red flag.

It indicates early active diabetic nephropathy.

The high blood sugars are beginning to destroy the glomerular barrier.

The clinical management here must be rapid and aggressive.

He needs strict glycemic control with medications like metformin and glycozide.

Crucially, he must be started on an ACE inhibitor for his blood pressure.

ACE inhibitors specifically reduce the pressure inside the glomeruli, protecting the delicate barrier and halting the progression toward end -stage chronic kidney disease.

Proteinuria can also be tubular.

In rare conditions like Fanconi's syndrome, the glomerulus filters perfectly, but the renal tubules are damaged.

And they fail to reabsorb normally filtered low -molecular weight proteins like retinal -binding proteins.

Lastly, you can have overflow proteinuria.

This happens when the kidneys are perfectly healthy, but the bloodstream is so completely overwhelmed by massive amounts of small proteins.

Like Benz -Jones proteins in myeloma.

Or myoglobin released from crushed muscles.

That the intact kidneys simply cannot reabsorb the sheer volume.

The most severe manifestation of urinary protein loss, however, is nephrotic syndrome.

The diagnostic criteria represent a devastating domino effect.

It starts with massive structural damage to the glomeruli, resulting in the loss of more than three grams of protein into the urine every single day.

Because so much albumin is being flushed away, the patient develops profound hypoalbuminemia.

As we discussed earlier, losing albumin means losing your vascular osmotic pressure.

The fluid shifts out of the blood.

Resulting in the third criteria, severe widespread clinical edema.

Finally, the liver panics.

It senses the critically low osmotic pressure and desperately tries to compensate by blindly ramping up the production of all available proteins, including lipoproteins.

This massive overproduction causes the fourth criteria, severe hyperlipidemia.

We can gauge a patient's prognosis by measuring the physical selectivity of the protein loss.

If the ratio comparing the clearance of large IgG molecules to the clearance of smaller transferrin molecules is less than 0 .2, it is considered selective proteinuria.

This means the barrier is damaged but still repelling large molecules.

This has a favorable prognosis and usually responds well to steroid treatment.

Case 3 shows us what this looks like when a patient walks through the door.

A 47 -year -old man presents with severe bilateral ankle edema.

His fasting labs are shocking.

His cholesterol is highly elevated at 9 .4.

His albumin has crashed to 28.

And a 24 -hour urine collection confirms a massive 7 .8 grams of urinary protein loss.

A renal biopsy confirms focal segmental glomerulosclerosis as the cause of his nephrotic syndrome.

To figure all of this out systematically in a new patient, there's a clear diagnostic flow.

First, you must always rule out a simple urinary tract infection which can cause mild protein shedding.

Then ensure the protein area isn't just transient from a recent fever or benign orthostatic leakage.

Once those are ruled out, you check the ACR to accurately quantify the daily loss.

Finally, you run a urine electrophoresis to see exactly which specific proteins are leaking.

This tells you definitively whether the defect is glomerular, tubular, or overflow.

And a quick warning about relying on cheap albustics screening dipsticks in the clinic.

They are prone to false positives if the patient's urine is highly alkaline, actively infected, or if the collection cup was contaminated with certain disinfectants.

Always confirm the results with laboratory quantification.

As we wrap up, I want to leave you with a final clinical pearl regarding blood sampling.

We already discussed keeping cryoglobulin samples warm at 37 degrees and using serum to avoid the fibrinogen band.

But when you are drawing the blood, you must avoid prolonged venous stasis.

If you leave the tourniquet strapped around the patient's arm for too long, the hydrostatic pressure literally squeezes water out of the local veins.

This artificially concentrates the blood remaining in the vein and will give you a falsely elevated total protein reading on the lab report.

Understanding the deep interconnectedness of these pathways leaves me with a final provocative thought.

We've discussed how Bentz -Jones proteins and amyloid fibrils cause massive irreversible tissue damage simply by misfolding into beta -pleated sheets and physically accumulating.

If the root cause of these devastating diseases is ultimately a physical structural geometry problem, could the future of medicine lie outside of traditional chemistry?

You mean something mechanical.

Exactly.

Could we eventually engineer molecular nanoscavengers microscopic machines, designed specifically to physically hunt down, bind to, and manually untangle these rogue protein structures before they crash the biological system?

If we could approach amyloid deposition as a physical structural engineering problem, rather than just trying to alter cellular chemistry, it would fundamentally revolutionize how we treat everything from multiple myeloma to Alzheimer's disease.

Definitely something to ponder as you review your pathways tonight.

A very warm thank you for tuning into this deep dive session from the Last Minute Lecture tutoring team.

Best of luck with your clinical biochemistry studies.

You've got this!